Michael A. Mussallem net worth and biography

Michael Mussallem Biography and Net Worth

What is Michael A. Mussallem's net worth?

The estimated net worth of Michael A. Mussallem is at least $13.26 million as of September 22nd, 2022. Mr. Mussallem owns 157,353 shares of Edwards Lifesciences stock worth more than $13,255,417 as of September 29th. This net worth estimate does not reflect any other assets that Mr. Mussallem may own. Additionally, Mr. Mussallem receives a salary of $2,880,000.00 as CEO at Edwards Lifesciences. Learn More about Michael A. Mussallem's net worth.

How old is Michael A. Mussallem?

Mr. Mussallem is currently 69 years old. There are 6 older executives and no younger executives at Edwards Lifesciences. Learn More on Michael A. Mussallem's age.

What is Michael A. Mussallem's salary?

As the CEO of Edwards Lifesciences Co., Mr. Mussallem earns $2,880,000.00 per year. Learn More on Michael A. Mussallem's salary.

How do I contact Michael A. Mussallem?

The corporate mailing address for Mr. Mussallem and other Edwards Lifesciences executives is ONE EDWARDS WAY, IRVINE CA, 92614. Edwards Lifesciences can also be reached via phone at (949) 250-2500 and via email at [email protected] Learn More on Michael A. Mussallem's contact information.

Has Michael A. Mussallem been buying or selling shares of Edwards Lifesciences?

In the last ninety days, Michael A. Mussallem has sold $5,660,201.25 of Edwards Lifesciences stock. Most recently, Michael A. Mussallem sold 19,875 shares of the business's stock in a transaction on Thursday, September 22nd. The shares were sold at an average price of $84.17, for a transaction totalling $1,672,878.75. Following the completion of the sale, the chief executive officer now directly owns 157,353 shares of the company's stock, valued at $13,244,402.01. Learn More on Michael A. Mussallem's trading history.

Who are Edwards Lifesciences' active insiders?

Edwards Lifesciences' insider roster includes Donald Bobo, Jr (VP), Daveen Chopra (VP), Kieran Gallahue (Director), Leslie Heisz (Director), Jean-Luc Lemercier (VP), Martha Marsh (Director), Michael Mussallem (CEO), Robert Sellers (VP), Catherine Szyman (VP), Scott Ullem (CFO), Nicholas Valeriani (Director), Huimin Wang (VP), Larry Wood (VP), and Bernard Zovighian (VP). Learn More on Edwards Lifesciences' active insiders.

Are insiders buying or selling shares of Edwards Lifesciences?

In the last year, Edwards Lifesciences insiders bought shares 1 times. They purchased a total of 1,500 shares worth more than $168,345.00. In the last year, insiders at the medical research company sold shares 47 times. They sold a total of 697,191 shares worth more than $75,888,566.94. The most recent insider tranaction occured on September, 22nd when CEO Michael A Mussallem sold 19,875 shares worth more than $1,672,878.75. Insiders at Edwards Lifesciences own 1.3 % of the company. Learn More about insider trades at Edwards Lifesciences.

Information on this page was last updated on 9/22/2022.

Michael A. Mussallem Insider Trading History at Edwards Lifesciences

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/22/2022Sell19,875$84.17$1,672,878.75157,353View SEC Filing Icon  
8/15/2022Sell19,875$104.74$2,081,707.50157,353View SEC Filing Icon  
7/14/2022Sell19,875$95.88$1,905,615.00166,853View SEC Filing Icon  
6/14/2022Sell19,875$86.96$1,728,330.00157,353View SEC Filing Icon  
5/10/2022Sell32,550$94.82$3,086,391.00157,353View SEC Filing Icon  
4/29/2022Sell32,550$107.80$3,508,890.0091,772View SEC Filing Icon  
3/22/2022Sell32,550$112.36$3,657,318.00View SEC Filing Icon  
2/15/2022Sell32,550$110.09$3,583,429.50View SEC Filing Icon  
1/6/2022Sell32,550$123.88$4,032,294.00View SEC Filing Icon  
12/20/2021Sell32,550$119.12$3,877,356.00View SEC Filing Icon  
11/9/2021Sell32,550$119.90$3,902,745.00View SEC Filing Icon  
10/1/2021Sell32,550$111.72$3,636,486.00View SEC Filing Icon  
8/3/2021Sell32,550$114.14$3,715,257.00233,052View SEC Filing Icon  
6/9/2021Sell32,550$97.23$3,164,836.50233,052View SEC Filing Icon  
5/24/2021Sell33,000$95.67$3,157,110.00221,002View SEC Filing Icon  
5/5/2021Sell35,550$92.28$3,280,554.0097,015View SEC Filing Icon  
4/8/2021Sell68,550$84.45$5,789,047.50309,770View SEC Filing Icon  
3/9/2021Sell68,550$82.66$5,666,343.00309,770View SEC Filing Icon  
2/23/2021Sell68,550$84.17$5,769,853.50309,770View SEC Filing Icon  
1/15/2021Sell68,550$87.50$5,998,125.00279,570View SEC Filing Icon  
12/14/2020Sell68,550$84.49$5,791,789.50309,770View SEC Filing Icon  
11/17/2020Sell68,550$85.09$5,832,919.50309,770View SEC Filing Icon  
10/9/2020Sell68,550$83.19$5,702,674.50309,770View SEC Filing Icon  
9/29/2020Sell68,550$78.74$5,397,627.00309,770View SEC Filing Icon  
8/19/2020Sell68,550$79.05$5,418,877.50309,770View SEC Filing Icon  
7/9/2020Sell68,550$68.22$4,676,481.00309,770View SEC Filing Icon  
6/15/2020Sell68,550$68.28$4,680,594.00
5/8/2020Sell22,850$219.58$5,017,403.0044,201View SEC Filing Icon  
4/7/2020Sell22,850$202.34$4,623,469.0069,976View SEC Filing Icon  
2/10/2020Sell22,850$229.62$5,246,817.0069,976View SEC Filing Icon  
1/3/2020Sell22,850$231.36$5,286,576.0069,976View SEC Filing Icon  
12/12/2019Sell22,850$229.60$5,246,360.0069,976View SEC Filing Icon  
11/15/2019Sell22,850$242.38$5,538,383.00
10/30/2019Sell22,850$238.79$5,456,351.5095,770View SEC Filing Icon  
9/10/2019Sell22,850$214.90$4,910,465.0095,770View SEC Filing Icon  
8/22/2019Sell22,850$216.70$4,951,595.0095,770View SEC Filing Icon  
7/9/2019Sell22,850$189.14$4,321,849.00105,770View SEC Filing Icon  
6/12/2019Sell22,850$184.27$4,210,569.5095,770View SEC Filing Icon  
5/10/2019Sell32,800$178.99$5,870,872.0084,601View SEC Filing Icon  
4/29/2019Sell32,800$174.73$5,731,144.0075,926View SEC Filing Icon  
3/8/2019Sell32,800$167.89$5,506,792.0067,126View SEC Filing Icon  
2/12/2019Sell32,800$176.90$5,802,320.0075,926View SEC Filing Icon  
1/3/2019Sell32,800$143.90$4,719,920.0075,926View SEC Filing Icon  
12/21/2018Sell32,800$146.03$4,789,784.0075,926View SEC Filing Icon  
11/19/2018Sell32,900$150.88$4,963,952.0076,026View SEC Filing Icon  
10/29/2018Sell32,900$140.74$4,630,346.00View SEC Filing Icon  
9/12/2018Sell32,900$144.02$4,738,258.0076,026View SEC Filing Icon  
8/7/2018Sell32,900$142.37$4,683,973.0076,026View SEC Filing Icon  
7/31/2018Sell32,900$141.86$4,667,194.0043,126View SEC Filing Icon  
5/17/2018Sell32,900$135.88$4,470,452.00112,731View SEC Filing Icon  
5/7/2018Sell32,800$136.37$4,472,936.0061,131View SEC Filing Icon  
4/30/2018Sell32,800$128.46$4,213,488.0074,131View SEC Filing Icon  
3/21/2018Sell32,800$139.74$4,583,472.0074,131View SEC Filing Icon  
2/13/2018Sell32,800$126.69$4,155,432.0074,131View SEC Filing Icon  
1/4/2018Sell32,800$114.97$3,771,016.00View SEC Filing Icon  
12/19/2017Sell32,800$114.82$3,766,096.00View SEC Filing Icon  
11/20/2017Sell32,900$106.86$3,515,694.00View SEC Filing Icon  
10/30/2017Sell32,900$100.93$3,320,597.00View SEC Filing Icon  
9/7/2017Sell32,900$112.45$3,699,605.00View SEC Filing Icon  
8/9/2017Sell32,900$115.99$3,816,071.00View SEC Filing Icon  
7/31/2017Sell32,900$114.80$3,776,920.00View SEC Filing Icon  
6/7/2017Sell32,900$118.05$3,883,845.00View SEC Filing Icon  
5/3/2017Sell49,100$109.71$5,386,761.00View SEC Filing Icon  
4/28/2017Sell49,100$109.78$5,390,198.00View SEC Filing Icon  
2/16/2017Sell49,100$89.63$4,400,833.00View SEC Filing Icon  
1/13/2017Sell49,100$97.08$4,766,628.00View SEC Filing Icon  
12/19/2016Sell49,100$91.96$4,515,236.00View SEC Filing Icon  
11/22/2016Sell49,100$84.67$4,157,297.00View SEC Filing Icon  
10/27/2016Sell49,100$92.77$4,555,007.00View SEC Filing Icon  
8/11/2016Sell49,100$114.01$5,597,891.00View SEC Filing Icon  
7/28/2016Sell49,100$113.31$5,563,521.00View SEC Filing Icon  
6/8/2016Sell49,100$102.75$5,045,025.00127,341View SEC Filing Icon  
5/5/2016Sell59,000$104.12$6,143,080.0068,256View SEC Filing Icon  
4/29/2016Sell59,000$106.13$6,261,670.0079,256View SEC Filing Icon  
3/17/2016Sell59,000$84.39$4,979,010.0080,650View SEC Filing Icon  
2/18/2016Sell59,000$86.94$5,129,460.00View SEC Filing Icon  
1/5/2016Sell59,000$79.82$4,709,380.0021,650View SEC Filing Icon  
12/17/2015Sell59,000$81.85$4,829,150.0021,650View SEC Filing Icon  
10/29/2015Sell29,500$154.59$4,560,405.0040,325View SEC Filing Icon  
9/21/2015Sell29,500$142.49$4,203,455.0010,825View SEC Filing Icon  
8/24/2015Sell29,500$135.25$3,989,875.00279,887View SEC Filing Icon  
6/24/2015Sell29,500$143.71$4,239,445.00View SEC Filing Icon  
4/30/2015Sell29,500$128.99$3,805,205.00View SEC Filing Icon  
3/26/2015Sell29,500$140.10$4,132,950.00View SEC Filing Icon  
1/5/2015Sell29,500$128.20$3,781,900.00View SEC Filing Icon  
12/22/2014Sell29,500$133.01$3,923,795.00View SEC Filing Icon  
11/24/2014Sell29,500$124.25$3,665,375.00View SEC Filing Icon  
10/28/2014Sell29,500$117.06$3,453,270.00View SEC Filing Icon  
9/29/2014Sell29,500$102.71$3,029,945.00View SEC Filing Icon  
8/27/2014Sell29,500$98.14$2,895,130.00View SEC Filing Icon  
7/31/2014Sell29,500$91.98$2,713,410.00View SEC Filing Icon  
6/24/2014Sell29,500$85.38$2,518,710.00View SEC Filing Icon  
5/28/2014Sell29,500$79.33$2,340,235.00View SEC Filing Icon  
7/10/2013Sell29,500$65.60$1,935,200.00View SEC Filing Icon  
6/6/2013Sell29,500$66.25$1,954,375.00View SEC Filing Icon  
5/8/2013Sell29,200$64.24$1,875,808.00View SEC Filing Icon  
4/10/2013Sell35,000$83.37$2,917,950.00View SEC Filing Icon  
8/9/2012Sell35,000$98.69$3,454,150.00View SEC Filing Icon  
See Full Table

Michael A. Mussallem Buying and Selling Activity at Edwards Lifesciences

This chart shows Michael A Mussallem's buying and selling at Edwards Lifesciences by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Edwards Lifesciences Company Overview

Edwards Lifesciences logo
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides the PASCAL and Cardioband transcatheter valve repair systems for minimally-invasive therapy. In addition, it offers surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; KONECT RESILIA, a pre-assembled aortic tissue valved conduit for patients who require replacement of the valve, root, and ascending aorta; and HARPOON Beating Heart Mitral Valve Repair System for patients with degenerative mitral regurgitation. Further, the company provides critical care solutions, including advanced hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
Read More

Today's Range

Now: $83.73
Low: $82.78
High: $84.42

50 Day Range

MA: $96.09
Low: $82.37
High: $107.29

2 Week Range

Now: $83.73
Low: $81.87
High: $131.73

Volume

80,141 shs

Average Volume

2,746,764 shs

Market Capitalization

$51.91 billion

P/E Ratio

36.25

Dividend Yield

N/A

Beta

1.14